You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for ASPIRIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ASPIRIN

Average Pharmacy Cost for ASPIRIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ASPIRIN 325 MG TABLET 51645-0716-01 0.01521 EACH 2024-12-18
ASPIRIN 325 MG TABLET 51645-0716-10 0.01521 EACH 2024-12-18
ASPIRIN 325 MG TABLET 49483-0011-10 0.01521 EACH 2024-12-18
ASPIRIN 325 MG TABLET 70000-0253-02 0.01521 EACH 2024-12-18
ASPIRIN 325 MG TABLET 00536-1054-29 0.01521 EACH 2024-12-18
ASPIRIN-DIPYRIDAM ER 25-200 MG 68462-0405-60 0.66460 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for ASPIRIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
ASPIRIN 325MG TAB EC Richmond Pharmaceuticals Inc. 54738-0111-01 100 1.54 0.01540 EACH 2024-02-15 - 2029-02-14 FSS
ASPIRIN 81MG TAB,EC Richmond Pharmaceuticals Inc. 54738-0559-12 120 0.96 0.00800 EACH 2024-02-15 - 2029-02-14 FSS
ASPIRIN 325MG TAB EC Richmond Pharmaceuticals Inc. 54738-0111-03 1000 9.90 0.00990 EACH 2024-02-15 - 2029-02-14 FSS
ASPIRIN 81MG TAB,EC Richmond Pharmaceuticals Inc. 54738-0559-25 250 2.10 0.00840 EACH 2024-02-15 - 2029-02-14 FSS
ASPIRIN 81MG TAB CHEWABLE Richmond Pharmaceuticals Inc. 54738-0128-36 36 0.56 0.01556 EACH 2024-02-15 - 2029-02-14 FSS
ASPIRIN 81MG TAB CHEWABLE Richmond Pharmaceuticals Inc. 54738-0128-90 90 1.14 0.01267 EACH 2024-02-15 - 2029-02-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

ASPIRIN Market Analysis and Financial Projection

Market Analysis and Price Projections for Aspirin

Introduction to the Aspirin Market

Aspirin, one of the most widely used medications globally, has a market that is driven by a combination of factors including increasing prevalence of chronic diseases, advancements in pharmaceutical formulations, and geopolitical influences. Here’s a comprehensive analysis of the aspirin market, including its current state, future projections, and the factors influencing its prices.

Global Aspirin Market Size and Forecast

The global aspirin market is projected to experience significant growth over the next few years. As of 2024, the market size is estimated to be around USD 2,938.2 million and is expected to expand at a CAGR of 3.8% to reach USD 4,236.9 million by 2034[1].

Another report indicates that the global aspirin market size was valued at USD 2.26 billion in 2024 and is projected to reach USD 2.75 billion by 2031, growing at a CAGR of 2.47% during the forecast period[3].

Regional Market Analysis

North America

North America, particularly the United States, holds a substantial share of the global aspirin market. The U.S. is expected to seize a 25.7% global market share in 2024, driven by the increasing need for aspirin to manage chronic pain. Chronic pain among adults, exacerbated by sedentary lifestyles, is a key driver in this region[1].

According to Cognitive Market Research, North America held more than 40% of the global revenue with a market size of USD 1005.8 million in 2024, and is expected to grow at a CAGR of 1.4% from 2024 to 2031[4].

Europe

Europe also constitutes a significant portion of the global aspirin market. The region held around 30% of the global revenue with a market size of USD 754.35 million in 2024 and is expected to grow at a CAGR of 1.7% from 2024 to 2031[4].

Asia Pacific

The Asia Pacific region, led by China, is another major market for aspirin. This region held around 23% of the global revenue with a market size of USD 578.34 million in 2024 and is expected to grow at a CAGR of 5.2% from 2024 to 2031[4].

Drivers of the Aspirin Market

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic conditions such as arthritis, cardiovascular diseases, and brain strokes is a significant driver of the aspirin market. Aspirin is widely used for managing chronic pain and as a preventive measure for cardiovascular diseases[1][4].

Public Awareness and Health Initiatives

Public and private organizations' initiatives to spread awareness about myocardial infarction and other cardiovascular diseases are expected to elevate the market scope further[1].

Novel Formulations

Advancements in pharmaceutical formulations, such as the use of aspirin in hydrogels, are also contributing to market growth. These novel formulations enhance the efficacy and usability of aspirin, attracting more consumers[3].

Price Projections and Trends

Current Price Trends

As of Q3 2024, aspirin prices have experienced a notable surge globally. In the United States, prices reached 3300 USD/MT by September, driven by robust demand, supply chain disruptions, and strategic inventory management by key market players[5].

In China, aspirin prices settled at 2890 USD/MT in September, influenced by seasonal demand shifts and cost movements. Germany saw a sharp rise in aspirin prices, reaching 3190 USD/MT, fueled by strong demand and supply chain challenges[5].

Factors Influencing Prices

  • Supply Chain Disruptions: Ongoing supply chain challenges, including port congestion and transportation delays, are significant factors driving prices higher[2][5].
  • Geopolitical Tensions: Escalating conflicts in regions crucial for energy security and trade routes, such as the Middle East, can lead to higher production and transportation costs, contributing to price increases[2].
  • Seasonal Demand: Seasonal fluctuations in demand, particularly during holidays like China's Golden Week, can lead to temporary reductions in supply and subsequent price hikes[2].
  • Economic Factors: Changes in consumer sentiment, interest rates, and inflation rates can also impact aspirin prices. For instance, improved consumer confidence in the U.S. and Europe has led to increased demand and higher prices[2][5].

Future Outlook

The aspirin market is expected to continue growing, driven by the increasing prevalence of chronic diseases and advancements in pharmaceutical formulations. However, the market may face challenges due to geopolitical tensions, supply chain disruptions, and fluctuations in global commodity prices.

Market Growth Projections

The global aspirin market is projected to grow at a CAGR of 3.8% from 2024 to 2034, reaching a valuation of USD 4,236.9 million by 2034[1]. Another projection indicates a CAGR of 3.20% from 2024 to 2031, reaching USD 3134.8 million by 2031[4].

Regional Growth

North America is expected to continue its strong performance, with the U.S. market growing at a CAGR of 1.2% from 2024 to 2031. The Asia Pacific region, particularly China, is expected to see robust growth with a CAGR of 5.2% during the same period[4].

Key Takeaways

  • The global aspirin market is expected to grow significantly, driven by the increasing prevalence of chronic diseases and advancements in pharmaceutical formulations.
  • North America, particularly the U.S., holds a substantial share of the global market.
  • Supply chain disruptions, geopolitical tensions, and seasonal demand shifts are key factors influencing aspirin prices.
  • The market is projected to grow at a CAGR of 3.8% from 2024 to 2034, reaching a valuation of USD 4,236.9 million by 2034.

FAQs

What is the current global market size of the aspirin market?

The global aspirin market size is estimated to be around USD 2,938.2 million in 2024[1].

What are the primary drivers of the aspirin market?

The primary drivers include the increasing prevalence of chronic diseases such as arthritis, cardiovascular diseases, and brain strokes, as well as public awareness and health initiatives[1][4].

Why are aspirin prices expected to rise in 2024?

Aspirin prices are expected to rise due to increased demand, supply chain disruptions, constrained market inventories, and geopolitical tensions[2][5].

Which region is expected to see the highest growth in the aspirin market?

The Asia Pacific region, particularly China, is expected to see the highest growth with a CAGR of 5.2% from 2024 to 2031[4].

How do seasonal demand shifts impact aspirin prices?

Seasonal demand shifts, such as those during China's Golden Week, can lead to temporary reductions in supply and subsequent price hikes[2].

Sources

  1. Future Market Insights: Aspirin Drug Market Size, Share & Forecast to 2034.
  2. ChemAnalyst: Aspirin Costs Skyrocket: Global Markets Brace for October Price Shock.
  3. Verified Market Research: In-Depth Industry Outlook: Aspirin Market Size & Forecast.
  4. Cognitive Market Research: Global Aspirin Market Report 2024.
  5. Pando: Latest Aspirin Prices, Price Trend & Forecast.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.